Quick Takeaways
- Saturn V Capital Management LP filed SCHEDULE 13G for Immix Biopharma, Inc. Common Stock (IMMX).
- Disclosed ownership: 7%.
- Date of event: 26 Dec 2025.
Saturn V Capital Management LP - 26 Dec 2025 SCHEDULE 13G Report for Immix Biopharma, Inc. Common Stock (IMMX)
- Filing Manager
- Saturn V Capital Management LP
- Reporting Manager
- Saturn V Capital Management LP
- Security
- Immix Biopharma, Inc. Common Stock
- Symbol
- IMMX
- Shares outstanding
- 52,992,611 shares
- Disclosed Ownership
- 3,693,585 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 14:50:01 UTC
- Date of event
- 26 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Saturn V Capital Management LP disclosed 7% ownership in Immix Biopharma, Inc. Common Stock (IMMX) on 26 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 14:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Saturn V Capital Management LP | 7% | 3,693,585 | 0 | 3,693,585 | Xiaoying Tian | Xiaoying Tian, Managing Member of SVCM GP LLC, the General Partner of Saturn V Capital Management LP | |
| Xiaoying Tian | 7% | 3,693,585 | 0 | 3,693,585 | Xiaoying Tian | Xiaoying Tian |